News
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
Palantir Technologies raises its full-year outlook but the stock falls, while Ford suspends guidance because of uncertainty ...
The decision comes after Cornell University canceled one of the singer's upcoming concerts, citing her stance on the ...
Toy-maker Mattel Inc. on Monday said it plans to raise prices in the U.S. "where necessary" on some toys and take steps to rely less on China for production, while pausing its full-year outlook as it ...
Rosalía Dishes on ‘Euphoria’ Acting Debut During Met Gala Interview: “Trying Not to Forget My Lines”
The superstar singer from Spain stepped out in an all-white sculptured creation by Olivier Rousteing at Balmain: “I’m his ...
Hims & Hers Health (NYSE:HIMS) reported a strong financial performance for Q1 2025, with revenue reaching $586 million, ...
Explore Hims & Hers' impressive Q1 2025 growth with 111% revenue increase, strategic partnerships, and innovative healthcare solutions.
Hims & Hers Health reports strong Q1 results with 111% revenue growth, 38% subscriber growth, and sets 2030 targets. Read ...
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 66.67% and 8.91%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
That controversial Super Bowl ad appears to have paid off for Hims & Hers as the company's first-quarter revenue doubled year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results